Surgical pathology is the branch of medicine where tissue removed from a living patient is examined under a microscope to diagnose disease. It falls within the broader field of anatomic pathology and is the primary way cancers, infections, inflammatory conditions, and many other diseases are definitively identified. When your doctor sends a biopsy or a surgically removed organ to “the lab,” it’s a surgical pathologist who examines that tissue and writes the report that guides your treatment.
How It Differs From Other Types of Pathology
Pathology as a whole is the study of disease, but it branches into distinct disciplines. Clinical pathology deals with blood tests, urine analysis, and other body fluids. Anatomic pathology focuses on tissue and includes autopsies, cytopathology (the study of individual cells), and surgical pathology. What sets surgical pathology apart is its focus on tissue specimens taken from living patients, usually during a biopsy or surgery, with the goal of making a diagnosis that directly shapes treatment decisions.
The field emerged in the late 1800s, when advances in microscopy, anesthesia, and antiseptic technique converged. For the first time, doctors could remove a small piece of tissue from a living patient, study it under a microscope, and classify the disease before deciding on further surgery. That basic workflow remains the backbone of surgical pathology today, though the tools have grown far more sophisticated.
What Happens to Your Tissue Sample
The journey from operating room to diagnosis follows a carefully controlled sequence. Every step exists to preserve the tissue’s structure and ensure the right sample is linked to the right patient.
First, the specimen is transferred from surgery to the pathology lab and matched to the patient using identifiers like name, date of birth, and medical record number. This identification step is considered the single most important part of specimen handling, because a mislabeled sample could lead to a wrong diagnosis for two patients at once.
Next comes the gross examination, sometimes called “grossing.” A pathologist or trained assistant opens the container and describes the tissue with the naked eye: its size, color, consistency, number of fragments, and any landmarks like surgical sutures that indicate orientation. If it’s a large specimen, such as a section of colon removed for cancer, the pathologist selects specific areas to sample for microscopic review, noting exactly where each slice came from.
The tissue is then placed in a chemical preservative, typically a solution called formalin. Fixation prevents the tissue from decomposing, preserves its microscopic architecture, and locks molecular components in place. The fixative needs to be at least ten times the volume of the specimen to work properly. After fixation, the tissue is embedded in wax, sliced into sections thinner than a human hair, mounted on glass slides, and stained so that different cell types become visible under the microscope.
Frozen Sections: Diagnosis During Surgery
Sometimes surgeons need an answer while the patient is still on the operating table. In these cases, a tissue sample is sent for a frozen section. Instead of the hours-long fixation and embedding process, the tissue is rapidly frozen, sliced on a specialized machine called a cryostat, stained, and examined within minutes. This lets the pathologist relay preliminary findings to the surgeon in real time.
Frozen sections are commonly used to determine whether a tumor is cancerous, whether the edges of removed tissue are free of cancer cells, or whether a biopsy contains enough diagnostic material. The tradeoff is that frozen tissue doesn’t preserve cellular detail quite as well as the standard process, so a final diagnosis is always confirmed later on the permanent, formalin-fixed slides.
What a Pathology Report Tells You
The pathology report is the end product of the entire process, and it’s one of the most important documents in your medical record. For a cancer diagnosis, the report typically includes several key pieces of information.
Tissue type and diagnosis: The report identifies exactly what the disease is, whether that’s a specific type of cancer, an infection, an autoimmune condition, or benign tissue.
Tumor grade: This describes how abnormal the cells look compared to normal tissue. Higher-grade tumors tend to grow and spread more aggressively. The pathologist assesses cell arrangement, behavior, and overall appearance to assign this grade.
Resection margins: If tissue was surgically removed, the pathologist checks whether cancer cells reach the edges of the specimen. A “negative” or “clean” margin means no cancer is found at the edge, suggesting the surgeon removed all of it. A “positive” or “involved” margin means cancer cells extend to the edge, which may mean additional surgery or treatment is needed.
Staging information: The report contributes to staging, which describes how far a cancer has spread in the body. Staging considers the size of the tumor, whether nearby lymph nodes contain cancer cells, and whether the disease has reached distant organs. This information is essential for planning treatment and estimating prognosis.
Specialized Tools Beyond the Microscope
Standard staining reveals a lot, but some diagnoses require additional techniques. Immunohistochemistry, or IHC, is one of the most widely used. It works by applying antibodies that bind to specific proteins in the tissue. If the protein is present, a visible color change appears on the slide. What makes IHC especially valuable is that it works without destroying the tissue’s architecture, so pathologists can see exactly which cells contain the protein and where they sit relative to surrounding structures.
Other techniques include molecular and genetic testing, which can identify specific mutations driving a cancer. These results increasingly determine which targeted therapies a patient is eligible for. Flow cytometry, which analyzes characteristics of individual cells in a fluid sample, is particularly useful for diagnosing blood cancers and lymphomas.
How Long Results Take
Turnaround time depends on the complexity of the case. A straightforward biopsy typically takes two to three days. Larger cancer resections, which require more tissue sampling, additional stains, and sometimes molecular testing, generally take around five days. Cases that need outside consultation or specialized genetic analysis can take longer.
Subspecialties Within Pathology
Surgical pathology itself is broad, but pathologists often develop expertise in specific organ systems or disease types. The American Board of Pathology recognizes numerous subspecialties, several of which overlap heavily with surgical pathology work.
- Dermatopathology focuses on skin diseases, from rashes to melanoma.
- Hematopathology covers diseases of blood cells, bone marrow, and lymph nodes.
- Neuropathology deals with diseases of the nervous system and skeletal muscles.
- Cytopathology specializes in diagnosing disease from individual cells rather than tissue sections, including Pap smears and fine-needle aspirations.
- Pediatric pathology focuses on diseases occurring during fetal development, infancy, and childhood.
- Molecular genetic pathology applies molecular biology techniques to diagnosis, increasingly important in the era of precision medicine.
Other recognized subspecialties include forensic pathology, medical microbiology, and clinical informatics, though these tend to sit further from the day-to-day surgical pathology bench.
Digital Pathology and AI
The field is in the middle of a significant technological shift. Digital pathology, which involves scanning glass slides into high-resolution digital images, has been evolving since early telepathology experiments in the 1960s and is now reaching broad adoption in laboratories worldwide. Digital slides can be shared instantly for remote consultation, archived without physical storage, and analyzed by software.
Artificial intelligence is the next layer. Deep learning algorithms, particularly those designed to analyze images, have demonstrated accuracy rates above 95% for certain skin cancer diagnoses. In one study of over 380 cases spanning basal cell carcinoma, squamous cell carcinoma, melanoma, and benign moles, an AI model achieved 98.7% accuracy in classifying tumor types. AI tools are also being developed to automate repetitive tasks like counting cell division figures or checking whether surgical margins are clear of cancer, freeing pathologists to focus on more complex diagnostic challenges.
Among dermatopathology specialists surveyed, 84.1% agreed that AI should be integrated into medical education. The technology also holds promise for regions with a shortage of pathologists, where digital platforms could extend diagnostic services to underserved areas. Still, AI functions as a support tool rather than a replacement. The pathologist remains the one who synthesizes all available information, from the microscopic appearance to the clinical history, and signs the final diagnosis.